Dr Shirley L Stack, PHD | |
170 Village Crest, Avila Beach, CA 93424-2442 | |
(805) 595-7936 | |
Not Available |
Full Name | Dr Shirley L Stack |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 170 Village Crest, Avila Beach, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366695447 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY14640 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Shirley L Stack, PHD Po Box 2442, Avila Beach, CA 93424-2442 Ph: (805) 595-7936 | Dr Shirley L Stack, PHD 170 Village Crest, Avila Beach, CA 93424-2442 Ph: (805) 595-7936 |
News Archive
Neuroblastoma is a cancer that develops in nerve tissue, most commonly in the glands around the kidneys. The gene MYCN is overexpressed in 20-25% of neuroblastoma, and MYCN-amplified neuroblastoma contributes to a considerable percentage of pediatric cancer-related deaths.
The University of Michigan is hosting the three-day summit that will focus attention on the widespread shortage of medical technologies to help sick children.
Self-weighing can be a useful tool to help adults control their weight, but for adolescents and young adults this behavior may have negative psychological outcomes. Researchers from the University of Minnesota tracked the self-weighing behaviors of more than 1,900 young adults as part of Project EAT (Eating and Activity in Teens and Young Adults) and found increases in self-weighing to be significantly related to increases in weight concern and depression and decreases in body satisfaction and self-esteem among females.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's Investigational Device Exemption (IDE) to conduct a human clinical trial for its BioFoamĀ® Surgical Matrix protein hydrogel technology.
In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.
› Verified 3 days ago
Dr. Erich Rueschenberg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6215 Playa Vista Place, Avila Beach, CA 93424 Phone: 805-595-7037 | |
Dr. Nancy G. Rueschenberg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2386 Playa Vista Place, Avila Beach, CA 93424 Phone: 805-595-7037 Fax: 805-595-2703 |